Delivery Order SPE2DB20D3104-SPE2DB24FV9D2
Award Date
9/3/24
Potential Completion Date
9/4/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,984,356 units of hydroxychloroquine 200 mg tablets. The contract, valued at $1,539.32, is a firm fixed-price delivery order with an ultimate completion date of August 30, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,492 units of Hydroxychloroquine 200 mg tablets in 100-count bottles. The contract has a potential value of $1,240.87 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,610.31 firm fixed price Delivery Order (SPE2DB23FV6G6) is for the supply of 4,560,694,177 units of Hydroxychloroquine 200 mg tablets. The contract has an ultimate completion date of April 25, 2023 and does not utilize any set-aside requirements, indicating open competition. Amerisourcebergen holds a...
This federal contract award is for the delivery of 4,560,256,895 units of hydroxychloroquine 200 mg tablets, priced at a firm fixed price of $2,766.59. The award was made on March 14, 2023, with a completion date of March 15, 2023, to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is not designated with any set-aside requirements, indicating open...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,558,464 tablets of Hydroxychloroquine 200 mg. The $2,909.44 firm fixed-price contract has a completion date of September 15, 2022. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical...
This federal contract award is a delivery order valued at $3,741.38 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,557,125,734 units of Hydroxychloroquine 200mg tablets in 100-count bottles. The contract has an ultimate completion date of May 6, 2022 and was awarded on May 5, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,727.92 firm fixed-price delivery order is for the supply of 4,566,077,675 units of hydroxychloroquine 200 mg tablets. The contract has an ultimate completion date of October 11, 2024. This award is a component of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, with identification number SPE2DB20D3103|SPE2DB22FP9K9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.32 firm fixed-price delivery order is for the supply of 4,558,528,321 units of hydroxychloroquine 200 mg tablets. The contract has a completion date of September 21, 2022 and was awarded on September 20, 2022. Amerisourcebergen, a for-profit...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,926.37 firm-fixed-price delivery order is for the supply of 4,559,118,916 units of 200 mg hydroxychloroquine tablets packaged in 100-count bottles. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, with an ID of SPE2DB20D3104|SPE2DB22FV6T9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,829.34 firm fixed-price delivery order is for the supply of 4,557,140 units of hydroxychloroquine 200mg tablets. The contract has an ultimate completion date of May 9, 2022 and was awarded on May 6, 2022. This award is not designated as a set-aside contract....